{
  "ticker": "PAR",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02972227",
  "id": "02972227",
  "pages": 2,
  "price_sensitive": false,
  "date": "20250724",
  "time": "0922",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250724/pdf/06m31slzmxf0zr.pdf",
  "summary": "**Investor Webinar Announcement:**  \n- **Event:** Phase 3 clinical trial (PARA_OA_012) update for iPPS in knee osteoarthritis.  \n- **Focus:** Trial design, regulatory alignment, and high probability of success (PoS).  \n- **Date/Time:** 31 July 2025, 9:00am AEST.  \n- **Recording/Presentation:** Will be posted post-event on company website.  \n\n*No material trading or capital markets information identified.*",
  "usage": {
    "prompt_tokens": 808,
    "completion_tokens": 104,
    "total_tokens": 912,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-07-23T23:35:08.012408"
}